Breathe Easier, Live Better: How RAVCARE COPD Can Empower You

Chronic obstructive pulmonary disease (COPD) is a serious lung condition affecting millions worldwide. While millions struggle with it, a staggering 70% remain undiagnosed. This makes early intervention and proper management crucial.

The Challenge: Getting Diagnosed and Staying on Top of COPD

Traditionally, diagnosing COPD relies on pulmonary function tests (PFTs). These tests are important, but scheduling them can be inconvenient. Even then, interpreting PFT results can be complex.

RAVCARE’s Secret Weapon: AI for Accurate Diagnosis and Beyond

RAVCARE COPD Digital Therapeutics steps in with a revolutionary approach. Our AI software analyzes PFT results with unmatched accuracy, exceeding even the combined expertise of multiple pulmonologists. This means faster, more reliable diagnoses, putting you on the path to better management sooner.

Revolutionizing Health by Reclaiming Cardiometabolic Well-being.

Empowering people to take control of their chronic conditions through personalized digital therapeutics.

The first and only DTx platform that collects patient vital sign data using smartphone collected PPG signals, analyses and triages, and produces diagnostic suggestions for clinicians.

Screens for vitals and blood glucose using a smartphone.

Capability to triage and diagnose based on collected and available data using AI.